Clinical Trial Update: ME-401 and R-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 study of ME-401 in combination with R-CHOP for newly diagnosed Diffuse Large B-Cell Lymphoma was terminated, with results posted on 2025-02-07.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• ME-401
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Deepa Jagadeesh | Conditions: Diffuse Large B-Cell Lymphoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-02-07